Halbert Hargrove Global Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34K Buy
+15
New +$2.25K ﹤0.01% 377
2025
Q4
Sell
-59
Closed -$7.6K 626
2025
Q3
$7.6K Buy
+59
New +$7.2K ﹤0.01% 361
2025
Q2
Sell
-3
Closed -$335 536
2025
Q1
$335 Buy
+3
New +$319 ﹤0.01% 544

Other funds holding NVS

Halbert Hargrove Global Advisors's NVS Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in Novartis (NVS) in Q2 2026: 15 shares worth $2.34K. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in NVS as recently as Q3 2025.

Halbert Hargrove Global Advisors first reported a position in NVS in Q1 2025 and has held it in 3 quarters since. The position peaked at $7.6K in Q3 2025. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Halbert Hargrove Global Advisors held 15 shares of Novartis worth $2.34K as of Q2 2026.
  • Novartis was a new Halbert Hargrove Global Advisors position in Q2 2026.
  • Novartis made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #377 holding.
  • Halbert Hargrove Global Advisors first reported a position in Novartis in Q1 2025 and has held it in 3 quarters since.
  • Halbert Hargrove Global Advisors's Novartis position peaked at $7.6K in Q3 2025.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.